The global congenital heart disease market is anticipated to grow at a significant CAGR of nearly 9.1% during the forecast period. Congenital heart disease also called congenital heart defect is a condition having abnormalities in heart structure from birth time. The disease affects the heart walls, valves, and blood vessels of the heart. Its symptoms include shortness of breath, arrhythmias, cyanosis, edema, tiring quickly upon exertion. The rise in the incidences of congenital heart disease has been witnessed over the years. For instance, as per the Centers for Disease Control and Prevention (CDC), congenital heart defects (CHDs) affect nearly 1% of?or about 40,000?births per year in the US. Approximately 1 in 100 babies are born with a heart defect in the US annually.

Free Sample Copy @ https://www.omrglobal.com/request-sample/congenital-heart-diseases-market

The global congenital heart market is segmented based on defect type, diagnosis, treatment, and end-user. Based on the defect type, the market is segmented into heart valve defects, heart wall defects, and blood vessel defects. Based on the diagnosis, the market is segmented into echocardiogram, chest X-ray, MRI scan, and others. Based on the treatment, the market is segmented into medications, implantable heart device, catheter procedures, open heart surgery, and heart transplant. Apart from this, by end-users, the market is segmented into hospitals and clinics, diagnostic centers, and others.

A Full Report of Global Congenital Heart Diseases Market is Available at:
https://www.omrglobal.com/industry-reports/congenital-heart-diseases-market

The market is further segmented based on regions including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others0, and the Rest of the World (the Middle East and Africa, and Latin America). North America has been predicted to dominate the global congenital heart disease market due to well-established health infrastructure, technological developments, favorable government initiatives, and the significant prevalence of CHD.

Global Congenital Heart Diseases Market – Segmentation
By Defect Type
Heart Valve Defects
Heart Wall Defects
Blood Vessel Defects
By Diagnosis
Echocardiogram
Chest X-Ray
MRI Scan
Others
By Treatment
Medications
Implantable Heart Devices
Catheter Procedures
Open Heart Surgery
Heart Transplant
By End-User
Hospitals and Clinics
Diagnostic Centres
Others

Global Congenital Heart Diseases Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories
AstraZeneca Plc
Becton Dickson & Co.
Bio-Rad Laboratories
Boston Scientific Corp.
Laboratory Corporation of America Holdings (LabCorp)
F. Hoffmann-La Roche Ltd.
Glaxosmithkline Plc
Janssen Pharmaceuticals, Inc.
Medtronic
Viatris Inc.
Novartis Ag
Pfizer, Inc.
Randox Laboratories Ltd.
Response Biomedical Corporation
Sanofi S.A.
Siemens Healthineers
Thermo Fisher Scientific Inc.
Vericel Corporation

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/congenital-heart-diseases-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404